Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Can...

by Xuelei Ma, Xiaoshan Wang, Jingwen Huang, Yingtai Chen, Jing Zhang, Binglan Zhang, Changle Shi, Lei Liu
Published 2016-01-01